Eric P Davidson Selected Research

AVE 7688

12/2012	Early loss of innervation of cornea epithelium in streptozotocin-induced type 1 diabetic rats: improvement with ilepatril treatment.
2/2012	Effect of inhibition of angiotensin converting enzyme and/or neutral endopeptidase on vascular and neural complications in high fat fed/low dose streptozotocin-diabetic rats.
10/2011	Effect of treatment of high fat fed/low dose streptozotocin-diabetic rats with Ilepatril on vascular and neural complications.
1/2011	Role of the effect of inhibition of neutral endopeptidase on vascular and neural complications in streptozotocin-induced diabetic rats.
1/2011	Effect of Treatment of Sprague Dawley Rats with AVE7688, Enalapril, or Candoxatril on Diet-Induced Obesity.
1/2009	Vascular and neural dysfunctions in obese Zucker rats: effect of AVE7688.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eric P Davidson Research Topics

Disease

11	Type 2 Diabetes Mellitus (MODY) 09/2018 - 01/2008
9	Peripheral Nervous System Diseases (PNS Diseases) 09/2018 - 01/2012
7	Diabetic Neuropathies (Diabetic Neuropathy) 10/2015 - 02/2006
3	Hyperglycemia 01/2018 - 10/2015
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2012 - 01/2011
2	Cardiovascular Diseases (Cardiovascular Disease) 02/2015 - 02/2006
2	Obesity 01/2015 - 01/2011
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2009 - 01/2008
1	Weight Loss (Weight Reduction) 01/2015
1	Fatty Liver 01/2012
1	Insulin Resistance 10/2011
1	Experimental Diabetes Mellitus 01/2011
1	Glucose Intolerance 01/2011

Drug/Important Bio-Agent (IBA)

11	Streptozocin (Streptozotocin)FDA Link 09/2018 - 02/2006
8	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 10/2015 - 01/2008
7	Neprilysin (Neutral Endopeptidase)IBA 01/2018 - 01/2009
6	Menhaden oilIBA 01/2018 - 01/2012
6	AVE 7688IBA 12/2012 - 01/2009
5	Enalapril FDA LinkGeneric 06/2017 - 01/2008
4	Pharmaceutical PreparationsIBA 01/2018 - 01/2009
3	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 10/2015 - 01/2012
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2015 - 02/2006
2	Angiotensin Receptor AntagonistsIBA 01/2018 - 02/2006
2	Thioctic Acid (Lipoic Acid)IBA 06/2017 - 10/2015
2	AntioxidantsIBA 10/2015 - 01/2008
2	Glucose (Dextrose)FDA LinkGeneric 01/2015 - 01/2012
2	Vasopeptidase InhibitorsIBA 12/2012 - 02/2012
2	LipidsIBA 01/2012 - 01/2008
1	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2018
1	salicylsalicylic acid (salsalate)IBA 01/2018
1	Ophthalmic Solutions (Eye Drops)IBA 01/2016
1	lardIBA 01/2012
1	AcidsIBA 01/2012
1	AdiponectinIBA 01/2012
1	Calcitonin Gene-Related PeptideIBA 10/2011
1	Acetylcholine (Acetylcholine Chloride)FDA Link 10/2011
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 01/2011
1	candoxatrilIBA 01/2011
1	Rosuvastatin Calcium (Crestor)FDA Link 01/2008
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2008
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 02/2006

Therapy/Procedure

1	Therapeutics 10/2015